EUVIMEDEUVIMED entdecken
Open Access

Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery

Laxman Subedi, In Ho Im, Arjun Dhwoj Bamjan, Jiwon Jeon, Susmita Phuyal, Yun-Hwa Jeong, Seung Hyun Kim, Jung-Hyun Shim, Jeong Uk Choi, Jin Woo Park

Theranostics · 2026

DOI: 10.7150/thno.124189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Laxman Subedi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Je…. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Nanoparticles. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisTriple Negative Breast NeoplasmsNanoparticlesAnimalsFemaleHumansAdministration, OralMiceCell Line, TumorAdministration, MetronomicAntineoplastic AgentsTumor MicroenvironmentDrug Delivery SystemsLipids

Stichwörter der Autor:innen

combination chemotherapyferroptosisimmune modulationmetronomic low-dose regimenmultimodal transporter-facilitated absorptionoral nanoplatform

Substanzen

Antineoplastic AgentsLipids

Autor:innen und Institutionen

  • Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.
  • Biomedicine Cutting Edge Formulation Technology Center, Mokpo National University, Jeonnam 58554, Republic of Korea.
  • Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.
  • College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.

Zitieren

APA

Subedi, L., Im, I. H., Bamjan, A. D., Jeon, J., Phuyal, S., Jeong, Y. H., Kim, S. H., Shim, J. H., Choi, J. U., & Park, J. W. (2026). Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery. Theranostics. https://doi.org/10.7150/thno.124189

Vancouver

Subedi L, Im IH, Bamjan AD, Jeon J, Phuyal S, Jeong YH, et al. Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery. Theranostics. 2026. doi:10.7150/thno.124189

BibTeX
@article{Subedi2026,
  author = {Subedi, Laxman and Im, In Ho and Bamjan, Arjun Dhwoj and Jeon, Jiwon and Phuyal, Susmita and Jeong, Yun-Hwa and Kim, Seung Hyun and Shim, Jung-Hyun and Choi, Jeong Uk and Park, Jin Woo},
  title = {Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.124189}
}
Kostenlos starten →